Please assess the completion status of the following clinical trial:

Trial Title: Rheumatoid Arthritis Patients on Adalimumab to Evaluate Its Effect on Synovitis Using Ultrasonography in an Egyptian Population

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~A patient will be enrolled in this study if he/she fulfills ALL of the following criteria:~* Male or Female patients ≥ 18 years of age with diagnosis of RA~* Patient is eligible to start adalimumab therapy according to the local product label and prescription guidelines~* Patient is naïve to all biologics e.g. anti-cluster of differentiation 4 (anti-CD4) and anti-TNF treatments at the start of the study~* Patient has no history of inflammatory arthritis other than rheumatoid arthritis~* Patient has no history of lymphoma or leukemia or other malignancies~* Has negative result of tuberculosis (TB) screening test or is receiving TB prophylaxis as per local guidelines, Provided written Authorization to the investigator to use and/or disclose personal and/or health data, or Informed Consent if requested by the Local Regulations~Exclusion Criteria:~* Patients that are not diagnosed with rheumatoid arthritis as judged by the American College of Rheumatology criteria~* Patient is currently diagnosed with any condition other than rheumatoid arthritis that may affect radiography progression~* Susceptibility to infections including TB, as judged by the investigator~* Patient is carrier of Hepatitis B virus~* Patient is a pregnant or lactating female at the time of screening

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Rheumatoid Arthritis (RA) participants (Type: None): Male or female participants at least 18 years of age with diagnosis of RA

Based on this trial design, predict the completion outcome and termination type (if applicable).